A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Public ClinicalTrials.gov record NCT06431373. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis
Study identification
- NCT ID
- NCT06431373
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Priovant Therapeutics, Inc.
- Industry
- Enrollment
- 371 participants
Conditions and interventions
Conditions
Interventions
- Brepocitinib PO QD Drug
- Placebo PO QD Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2024
- Primary completion
- Sep 10, 2026
- Completion
- Jan 31, 2028
- Last update posted
- Jan 11, 2026
2024 – 2028
United States locations
- U.S. sites
- 53
- U.S. states
- 23
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Trial Site | Phoenix | Arizona | 85020 | — |
| Clinical Trial Site | Phoenix | Arizona | 85054 | — |
| Clinical Trial Site | Bakersfield | California | 93309 | — |
| Clinical Trial Site | Beverly Hills | California | 90211 | — |
| Clinical Trial Site | Fullerton | California | 92835 | — |
| Clinical Trial Site | Irvine | California | 92697 | — |
| Clinical Trial Site | La Jolla | California | 92093 | — |
| Clinical Trial Site | Los Angeles | California | 90033 | — |
| Clinical Trial Site | Los Angeles | California | 90095 | — |
| Clinical Trial Site | Modesto | California | 95356 | — |
| Clinical Trial Site | Sacramento | California | 92825 | — |
| Clinical Trial Site | Aurora | Colorado | 80045 | — |
| Clinical Trial Site | Denver | Colorado | 80246 | — |
| Clinical Trial Site | Fort Lauderdale | Florida | 33308 | — |
| Clinical Trial Site | St. Petersburg | Florida | 33711 | — |
| Clinical Trial Site | Chicago | Illinois | 60637 | — |
| Clinical Trial Site | Oak Park | Illinois | 60304 | — |
| Clinical Trial Site | Carmel | Indiana | 46290 | — |
| Clinical Trial Site | Prairie Village | Kansas | 66208 | — |
| Clinical Trial Site | Baltimore | Maryland | 21287 | — |
| Clinical Trial Site | Boston | Massachusetts | 02114 | — |
| Clinical Trial Site | Waltham | Massachusetts | 02451 | — |
| Clinical Trial Site | Ann Arbor | Michigan | 48105 | — |
| Clinical Trial Site | Detroit | Michigan | 48201 | — |
| Clinical Trial Site | Detroit | Michigan | 48202 | — |
| Clinical Trial Site | Minneapolis | Minnesota | 55455 | — |
| Clinical Trial Site | Rochester | Minnesota | 55905 | — |
| Clinical Trial Site | St Louis | Missouri | 63108 | — |
| Clinical Trial Site | Omaha | Nebraska | 68105 | — |
| Clinical Trial Site | Palisades Park | New Jersey | 07650 | — |
| NYU Langone Health | New York | New York | 10017 | — |
| Clinical Trial Site | Rochester | New York | 14642 | — |
| Clinical Trial Site | Durham | North Carolina | 27705 | — |
| Clinical Trial Site | Winston-Salem | North Carolina | 27157 | — |
| Clinical Trial Site | Cleveland | Ohio | 44106 | — |
| Clinical Trial Site | Cleveland | Ohio | 44195 | — |
| Clinical Trial Site | Columbus | Ohio | 43212 | — |
| Clinical Trial Site | Portland | Oregon | 97221 | — |
| Clinical Trial Site | Portland | Oregon | 97239 | — |
| Clinical Trial Site | Erie | Pennsylvania | 16507 | — |
| Clinical Trial Site | Philadelphia | Pennsylvania | 19107 | — |
| Clinical Trial Site | Philadelphia | Pennsylvania | 19141 | — |
| Clinical Trial Site | Greenville | South Carolina | 29605 | — |
| Clinical Trial Site | Nashville | Tennessee | 37232 | — |
| Clinical Trial Site | Austin | Texas | 78712 | — |
| Clinical Trial Site | Bellaire | Texas | 77401 | — |
| Clinical Trial Site | Dallas | Texas | 75390 | — |
| Clinical Trial Site | Houston | Texas | 77025 | — |
| Clinical Trial Site | Katy | Texas | 77494 | — |
| Clinical Trial Site | Plano | Texas | 75075 | — |
| Clinical Trial Site | Round Rock | Texas | 78681 | — |
| Clinical Trial Site | San Antonio | Texas | 78230 | — |
| Clinical Trial Site | Madison | Wisconsin | 53705 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 54 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06431373, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2026 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06431373 live on ClinicalTrials.gov.